nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

04.03.2021 | Original Article

Association of Wender Utah Rating Scale (WURS)-61 items with clinical psychiatric diagnosis in adulthood

verfasst von: Cliodhna Hanley, Faisal Saleem, Ignazio Graffeo, Geraldine McCarthy, Blánaid Gavin, Fiona McNicholas, Dimitrios Adamis

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The Wender Utah Rating Scale (WURS) is a widely used retrospective scale in adults presenting for ADHD evaluations which features items relating to childhood symptoms.

Aims

The aim of this study is to establish if certain childhood symptoms (including ADHD) as identified by the WURS-61 are associated with specific mental health disorders in adulthood.

Methods

Case-control study of N=630 attending Adult Mental Health Services (AMHS) and a control group without mental disorders (N=96).

Results

The mean age of the participants was 39.81 (SD 12.94) of which 387 (53.3%) were females. There were no significant differences between cases and controls in terms of age (t= 1.829, df 724, p=.068) and gender (x²=1.123, df 1, p=.289). Exploratory factor analysis of WURS-61 reveals 5 factors. Using factor scores and after cross-tabulation, we found that: The presence of childhood impulsivity, emotional lability and distress in addition to inattention/disorganisation were significantly associated with adult ADHD diagnosis (F90). WURS items which suggests childhood conduct problems were associated with a number of adult diagnoses, when present either on its own (psychoactive substance use, or when present in combination with childhood impulsivity, emotional lability and distress (personality disorders).

Conclusion

There is an association between certain childhood behaviours and risk for later development of personality disorders, and psychoactive substance use. There is overlap of childhood symptoms to those who later diagnosed in adulthood with ADHD, personality disorders, and substance abuse.

Ward MF, Wender PH, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychaitry 150(6):885–890CrossRef

Shaffer D (1994) Attention deficit hyperactivity disorder in adults. Am J Psychaitry 151(5):633–638. https://doi.org/10.1176/ajp.151.5.633CrossRefPubMed

Taylor A, Deb S, Unwin G (2011) Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. Res Dev Disabil 32(3):924–938. https://doi.org/10.1016/j.ridd.2010.12.036CrossRefPubMed

Fossati A, Ceglie A, Acquarini Di E et al (2001) The retrospective assessment of childhood attention deficit hyperactivity disorder in adults: reliability and validity of the Italian version of the Wender Utah Rating Scale. Compr Psychiatry 42(4):326–336 S0010-440X(01)68697-8[pii]https://doi.org/10.1053/comp.2001.24584

Rossini ED, O’Connor MA (1995) Retrospective self-reported symptoms of attention-deficit hyperactivity disorder: reliability of the Wender Utah Rating Scale. Psychol Rep 77(3 Pt 1):751–754CrossRef

McCann BS, Scheele L, Ward N, Roy-Byrne P (2000) Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 12(2):240–245CrossRef

Stanton K, Watson D (2016) An examination of the structure and construct validity of the Wender Utah Rating Scale. J Pers Assess 98(5):545–552. https://doi.org/10.1080/00223891.2016.1152579CrossRefPubMed

Adamis D, Graffeo I, Kumar R et al (2018) Screening for attention deficit-hyperactivity disorder (ADHD) symptomatology in adult mental health clinics. Ir J Psychol Med 35(3):193–201. https://doi.org/10.1017/ipm.2017.492017.49CrossRefPubMed

Goldberg DP, Hillier VF (1979) A scaled version of the General Health Questionnaire. Psychol Med 9(1):139–145. https://doi.org/10.1017/s0033291700021644CrossRefPubMed

10.

Martin AJ (1999) Assessing the multidimensionality of the 12-item General Health Questionnaire. Psychol Rep 84(3 Pt 1):927–935. https://doi.org/10.2466/pr0.1999.84.3.927CrossRefPubMed

11.

Simancas-Pallares M, Arrieta KM, Arevalo LL (2017) Construct validity and internal consistency of three factor structures and two scoring methods of the 12-item General Health Questionnaire. Biomedica : revista del Instituto Nacional de Salud 37(3):308–314. https://doi.org/10.7705/biomedica.v37i3.3240CrossRef

12.

Agresti A (2003) Categorical data analysis. John Wiley & Sons Inc, Hoboken, NJ

13.

Humphreys LG, Montanelli RG Jr (1975) An investigation of the parallel analysis criterion for determining the number of common factors. Multivar Behav Res 10(2):193–205CrossRef

14.

Wilens TE, Faraone SV, Biederman J (2004) Attention-deficit/hyperactivity disorder in adults. Jama 292(5):619–623. https://doi.org/10.1001/jama.292.5.619CrossRefPubMed

15.

Faraone SV, Biederman J, Spencer T et al (2000) Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48(1):9–20. https://doi.org/10.1016/s0006-3223(00)00889-1CrossRefPubMed

16.

Hill BD, Pella RD, Singh AN et al (2009) The Wender Utah Rating Scale: Adult ADHD diagnostic tool or personality index? J Atten Disord 13(1):87–94. https://doi.org/10.1177/1087054708320384CrossRefPubMed

17.

Calamia M, Hill BD, Musso MW et al (2018) Factor structure and clinical correlates of the 61-item Wender Utah Rating Scale (WURS). Atten Def Hyp Disord 10(3):177–188. https://doi.org/10.1007/s12402-018-0251-3CrossRefPubMed

18.

Miller CJ, Flory JD, Miller SR et al (2008) Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry 69(9):1477–1484. https://doi.org/10.4088/jcp.v69n0916CrossRefPubMedPubMedCentral

19.

Smith TE, Samuel DB (2017) A multi-method examination of the links between ADHD and personality disorder. J Pers Disord 31(1):26–48. https://doi.org/10.1521/pedi_2016_30_236CrossRefPubMed

20.

Philipsen A (2006) Differential diagnosis and comorbidity of attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults. Eur Arch Psychiatry Clin Neurosci 256(Suppl 1):i42-46. https://doi.org/10.1007/s00406-006-1006-2CrossRefPubMed

21.

Fossati A, Madeddu F, Maffei C (1999) Borderline personality disorder and childhood sexual abuse: a meta-analytic study. J Pers Disord 13(3):268–280CrossRef

22.

Fossati A (2012) Adult attachment in the clinical management of borderline personality disorder. J Psychiatr Pract 18(3):159–171. https://doi.org/10.1097/01.pra.0000415073.36121.64CrossRefPubMed

23.

Fossati A, Gratz KL, Borroni S et al (2015) The relationship between childhood history of ADHD symptoms and DSM-IV borderline personality disorder features among personality disordered outpatients: the moderating role of gender and the mediating roles of emotion dysregulation and impulsivity. Compr Psychiatry 56:121–127. https://doi.org/10.1016/j.comppsych.2014.09.023CrossRefPubMed

24.

Mannuzza S, Klein RG, Bessler A et al (1993) Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50(7):565–576CrossRef

25.

Stepp SD, Burke JD, Hipwell AE, Loeber R (2012) Trajectories of attention deficit hyperactivity disorder and oppositional defiant disorder symptoms as precursors of borderline personality disorder symptoms in adolescent girls. J Abnorm Child Psychol 40(1):7–20. https://doi.org/10.1007/s10802-011-9530-6CrossRefPubMedPubMedCentral

26.

Young JT, Carruthers S, Kaye S et al (2015) Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Drug Alcohol Rev 34(6):683–693. https://doi.org/10.1111/dar.12249CrossRefPubMed

27.

van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W et al (2012) Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 122(1–2):11–19. https://doi.org/10.1016/j.drugalcdep.2011.12.0072011.12.007CrossRef

28.

Parmar A, Kaloiya G (2018) Comorbidity of personality disorder among substance use disorder patients: a narrative review. Indian J Psychol Med 40(6):517–527. https://doi.org/10.4103/IJPSYM.IJPSYM_164_18CrossRefPubMedPubMedCentral

29.

Liu TL, Yang P, Ko CH et al (2014) Association between ADHD symptoms and anxiety symptoms in Taiwanese adolescents. J Atten Disord 18(5):447–455. https://doi.org/10.1177/1087054712439936CrossRefPubMed

30.

Dan O, Raz S (2015) The relationships among ADHD, self-esteem, and test anxiety in young adults. J Atten Disord 19(3):231–239. https://doi.org/10.1177/1087054712454571CrossRefPubMed

31.

Stein MA, Sandoval R, Szumowski E et al (1995) Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. Psychopharmacology Bull 31(2):425–433PubMed

Titel: Association of Wender Utah Rating Scale (WURS)-61 items with clinical psychiatric diagnosis in adulthood
verfasst von: Cliodhna Hanley
Faisal Saleem
Ignazio Graffeo
Geraldine McCarthy
Blánaid Gavin
Fiona McNicholas
Dimitrios Adamis
Publikationsdatum: 04.03.2021
Verlag: Springer International Publishing
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 1/2022
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-021-02574-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Letter to the Editor: Very high cortisol concentration in adrenal venous sampling in primary aldosteronism—physiological or pathological

Transoral robotic surgery in Ireland: the beginning

Minding metabolism: targeted interventions to improve cardio-metabolic monitoring across early and chronic psychosis

On-admission plasma levels of BNP, MR-proADM, and cTnI in pediatric heart failure: contributions to diagnosis, prognosis, and outcome

Subjective symptoms and their association with psychiatric symptoms 3 months after ICU discharge: sub-analysis of a single-center prospective observational study